Michelle Ananda‐Rajah

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus

Paul E. Verweij, Michelle Ananda‐Rajah, David R. Andes et al. · Drug Resistance Updates · 2015 · 330 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Mucormycosis in Australia: contemporary epidemiology and outcomes

Karina Kennedy, Kathryn Daveson, Monica A. Slavin et al. · Clinical Microbiology and Infection · 2016 · 126 citations · Full text

Dentistry, Infectious Diseases, Oral Pathology +12

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period

Michelle Ananda‐Rajah, A. Grigg, M. Downey et al. · Haematologica · 2011 · 107 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring

Michelle K. Yong, Michelle Ananda‐Rajah, Paul Cameron et al. · Biology of Blood and Marrow Transplantation · 2017 · 95 citations · Full text

Life Sciences, Hematology, Infectious Diseases +16

Attributable Hospital Cost and Antifungal Treatment of Invasive Fungal Diseases in High-Risk Hematology Patients: an Economic Modeling Approach

Michelle Ananda‐Rajah, Allen Cheng, C. Orla Morrissey et al. · Antimicrobial Agents and Chemotherapy · 2011 · 83 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-benefit Analysis +16